ATE550943T1 - Isoliertes dna-fragment des menschlichen sparc- promoters und seine verwendung - Google Patents

Isoliertes dna-fragment des menschlichen sparc- promoters und seine verwendung

Info

Publication number
ATE550943T1
ATE550943T1 AT07776311T AT07776311T ATE550943T1 AT E550943 T1 ATE550943 T1 AT E550943T1 AT 07776311 T AT07776311 T AT 07776311T AT 07776311 T AT07776311 T AT 07776311T AT E550943 T1 ATE550943 T1 AT E550943T1
Authority
AT
Austria
Prior art keywords
dna fragment
isolated dna
human sparc
sparc promoter
promoter
Prior art date
Application number
AT07776311T
Other languages
German (de)
English (en)
Inventor
Osvaldo Podhajcer
Eduardo Cafferata
Maria Lopez
Diego Viale
Original Assignee
Inis Biotech Llc
Inis Biotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inis Biotech Llc, Inis Biotech Sa filed Critical Inis Biotech Llc
Application granted granted Critical
Publication of ATE550943T1 publication Critical patent/ATE550943T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07776311T 2006-04-28 2007-04-26 Isoliertes dna-fragment des menschlichen sparc- promoters und seine verwendung ATE550943T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP060101724A AR053246A1 (es) 2006-04-28 2006-04-28 Un fragmento aislado de adn del promotor humano de sparc y su uso para dirigir la expresion de un gen heterologo en celulas tumorales
PCT/US2007/010196 WO2007127347A2 (en) 2006-04-28 2007-04-26 An isolated dna fragment of the sparc human promoter and its use

Publications (1)

Publication Number Publication Date
ATE550943T1 true ATE550943T1 (de) 2012-04-15

Family

ID=38006653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07776311T ATE550943T1 (de) 2006-04-28 2007-04-26 Isoliertes dna-fragment des menschlichen sparc- promoters und seine verwendung

Country Status (9)

Country Link
US (1) US8436160B2 (enExample)
EP (1) EP2048954B1 (enExample)
JP (1) JP5215290B2 (enExample)
AR (1) AR053246A1 (enExample)
AT (1) ATE550943T1 (enExample)
AU (1) AU2007243252B2 (enExample)
ES (1) ES2384736T3 (enExample)
NZ (1) NZ572350A (enExample)
WO (1) WO2007127347A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2304281B1 (es) * 2006-02-01 2009-08-12 Dnatrix Inc. Adenovirus oncoliticos para el tratamiento del cancer.
US9056133B2 (en) * 2011-05-25 2015-06-16 Cti-S.A. Pharmaceutical kit and method for treating cancer
WO2020172509A1 (en) * 2019-02-21 2020-08-27 Unleash Immuno Oncolytics, Inc. Oncolytic adenoviral vector and methods of use
EP4172208A2 (en) 2020-06-26 2023-05-03 Sorrento Therapeutics, Inc. Oncolytic herpes simplex viruses (hsv) expressing immunomodulatory fusion proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5772993A (en) * 1997-01-21 1998-06-30 The University Of Virginia Patent Foundation Osteocalcin promoter-based toxic gene therapy for the treatment of calcified tumors and tissues
WO2000072679A1 (en) * 1999-05-28 2000-12-07 University Of Virginia Patent Foundation Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
CA2530748A1 (en) * 2003-06-24 2005-02-24 Johns Hopkins University Methylated gene biomarkers for detecting cancer
WO2007000020A1 (en) 2005-06-29 2007-01-04 Compumedics Limited Sensor assembly with conductive bridge

Also Published As

Publication number Publication date
JP2009535031A (ja) 2009-10-01
JP5215290B2 (ja) 2013-06-19
WO2007127347A2 (en) 2007-11-08
WO2007127347A3 (en) 2008-01-03
EP2048954A2 (en) 2009-04-22
AR053246A1 (es) 2007-04-25
AU2007243252B2 (en) 2013-06-20
AU2007243252A1 (en) 2007-11-08
EP2048954A4 (en) 2009-12-02
ES2384736T3 (es) 2012-07-11
US8436160B2 (en) 2013-05-07
US20090312401A1 (en) 2009-12-17
EP2048954B1 (en) 2012-03-28
NZ572350A (en) 2011-12-22

Similar Documents

Publication Publication Date Title
EP2268813A4 (en) RNA MOLECULES AND USES THEREOF
EP2182969A4 (en) FIBROSIS MODULATING MICRO-RNA FAMILY AND METHODS OF USE THEREOF
EP2315849A4 (en) CIRCULATING MUTANT DNA FOR EVALUATING TUMOR DYNAMICS
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
ATE531712T1 (de) Substituierte aryloxazole und ihre verwendung
EP2122054A4 (en) NONWOVEN PANEL AND PRODUCTION METHOD THEREOF
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
EP1868650A4 (en) COVALENT DI-ANTIBODIES AND USES THEREOF
ATE432924T1 (de) 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten
DE602006008827D1 (de) Herbizidresistenz verleihende gene grg23 und grg51
EP2118320A4 (en) GENE CARD OF HUMAN GENES ASSOCIATED WITH HYPERACTIVITY ATTENTION DEFICIT DISORDER (ADHD)
EP1968612A4 (en) NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS
DK1577319T3 (da) Proteinoprensning med præfiltrering
EP1746902A4 (en) MULTI-LECTIN AFFINITY CHROMATOGRAPHY AND USES THEREOF
DE602007011906D1 (de) Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen
EP1910389A4 (en) SEPARATION AND PURIFICATION OF NUCLEIC ACID FROM PARAFFIN-SAMPLE SAMPLES
DE602008001981D1 (de) Stellung und therapeutische verwendung
EP2011883A4 (en) METHOD FOR PREDICTING TASK FORMATION ON THE SKIN AND METHOD FOR SCREENING TASK FORMATION INHIBITORS ON THE SKIN USING INCREASED TASK SITE INCREASE GENES
IL189611A0 (en) Treatment of inflammatory bowel disease
EP2315771A4 (en) GLYCOPEPTIDE CONSTRUCTS AND USES THEREOF
EP1955844A4 (en) COMPOSITE SHEET AND USE THEREOF
EP2305814A4 (en) Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
GB0809165D0 (en) Systems and methods of conducting clinical research
EP2275433A4 (en) METASTIN DERIVATIVE AND USE THEREOF
ATE550943T1 (de) Isoliertes dna-fragment des menschlichen sparc- promoters und seine verwendung